Leishmaniasis; Brazilian

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Leishmaniasis; Brazilian trials may be worth asking about

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (4 shown)

UnknownPhase 2/3

NCT06040489

Pilot Study: Oral Treatment of American Tegumentary Leishmaniasis (Cutaneous and Mucosal Forms) in the Elderly

Randomised clinical trial comparing oral miltefosine associated with pentoxifylline to intravenous liposomal amphotericin b for the treatment of cutaneous and m…

Brazil100 participantsStarted 2022-06-22Updated 2023-09-15

Treatment: Miltefosine 50mg, Pentoxifylline 400mg

CompletedPhase 4

NCT01032187

Amphotericin B to Treat Visceral Leishmaniasis in Brazilian Children

The purpose of this study is to determine if amphotericin B is effective against visceral leishmaniasis in Brazilian children. Amphotericin B will be compared t…

Brazil101 participantsStarted 2007-10Updated 2017-09-05

Treatment: Meglumine antimoniate, Amphotericin B-deoxycholate

TerminatedPhase 1/2

NCT00378495

Miltefosine for Brazilian Visceral Leishmaniasis

Miltefosine will be administered to Brazilian patients with kala azar

Brazil80 participantsStarted 2005-04Updated 2016-07-12

Treatment: Miltefosine: initially 2.5 mg/kg/day for 28 days

CompletedPhase 2

NCT00600548

Trial of Miltefosine in Cutaneous Leishmaniasis (Brazil)

The hypothesis of this trial is that the therapeutic activity and safety of oral miltefosine in Brazilian patients with cutaneous leishmaniasis is similar or su…

Brazil180 participantsStarted 2007-07Updated 2010-04-15

Treatment: Miltefosine., Meglumine antimoniate.